With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Platform development for target identification in high risk pediatric leukemias||St. Jude Children's Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8||2019||Tennessee|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD/PhD||Crazy 8||2019||New York|
|Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia||Harvard University / Nick van Gastel, PhD||Young Investigator Grants||2018||Massachusetts|
|Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients||Vanderbilt University Medical Center (Tennessee) / Rachael Schulte, MD||Young Investigator Grants||2018|
|Investigating the role of BAI1 in the Metastasis of Medulloblastoma||Emory University / Satoru Osuka, MD/PhD||Young Investigator Grants||2018||Georgia|
|Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish||Dana-Farber Cancer Institute / Serine Avagyan, PhD||Young Investigator Grants||2018||Massachusetts|
|NUDT15 Polymorphisms and Individualization of Thiopurine Therapy in Children with Acute Lymphoblastic Leukemia||St. Jude Children's Research Hospital / Takaya Moriyama, MD/PhD||Young Investigator Grants||2018||Tennessee|
|Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1||Northwestern University (Illinois) / Zibo Zhao, PhD||Young Investigator Grants||2018||Illinois|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Northwestern University (Illinois) / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|
|Identifying a Therapeutic Partner for TAK228 for Pediatric Phase II Brain Tumor Studies||The Johns Hopkins University School of Medicine / Eric H. Raabe, MD/PhD||Reach Grants||2018||Maryland|